Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Microrna microarray analysis of human adrenocortical tumours
Australian and New Zealand Journal of Surgery, 05/01/09
Soon PS et al. - The authors found miRs which were significantly differentially expressed between ACCs, ACAs and normal adrenal cortex, indicating that miRs are involved in the pathogenesis of adrenocortical tumours and have the potential to serve as diagnostic markers and therapeutic targets.
Related Articles
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification
Histopathology, 11/11/09
Relevance Score: 87%
Expression and Function of Endocannabinoid Receptors in the Human Adrenal Cortex
Hormone and Metabolic Research, 11/02/09
Relevance Score: 84%
The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09
Relevance Score: 84%
ACTH-Independent Cushing's Syndrome with Bilateral Micronodular Adrenal Hyperplasia and Ectopic Adrenocortical Adenoma
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Relevance Score: 83%
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09
Relevance Score: 82%
Today in Adrenal Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of antioxidant systems in pituitary-adrenal axis diseases
Pituitary, 12/18/09
Adrenal incidentalomas in the laparoscopic era and the role of correct surgical indications: observations from 255 consecutive adrenalectomies in an Italian series
Canadian Journal of Surgery, 12/18/09
Psychosomatic aspects of Cushings syndrome
Reviews in Endocrine and Metabolic Disease, 12/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Article Search
Sponsor


See Latest Articles


